Market Close Commentary; 22 July 2020

  • Jul 22, 2020 AEST
  • Team Kalkine

Today, the Australian stock market plunged by 1.32 per cent, settling the day trade at 6075.1. Yesterday, the benchmark index ended at 6,156.3. Other than the energy sector, all other sectors ended in the red zone. 

As per the latest government report, the total number of cases reported in Australia in the last 24 hours is 388. The retail data suggests that the panic buying has returned among consumers. Earlier it appeared that Australia could control the virus well, but the latest rising new cases and community transfer puts a grim picture of reality.

On Tuesday, the US stock market witnessed mixed performance with NASDAQ composite down by 0.81 per cent, Dow Industrials was up by 0.60 per cent, and S&P 500 surged by 0.17 per cent.

The stocks that performed the best today are:

  • Resolute Mining Limited (ASX:RSG), which traded at AUD400 and was up by 12.903 per cent on the back of its 2020 quarterly report presentation which shows guidance of 430koz at USD 980/oz AISC maintained for 2020; and
  • Challenger Limited (ASX:CGF), which traded at AUD 4.680 and was up by 7.094 per cent.

The weak performing stocks in today's market are:

  • Mesoblast Limited (ASX:MSB), Which traded at AUD 3.450, down by 6.757 per cent; and
  • Pro Medicus Limited (ASX:PME), which traded at AUD 24.490, down by 6.24 per cent.

See the graph here for the top five best and weakest performing stocks in today's market:

 


Disclaimer
The website https://kalkinemedia.com/au is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) or engage in any investment activity under discussion. We are neither licensed nor qualified to provide investment advice through this platform. All pictures are copyright to their respective owner(s). Kalkinemedia.com does not claim ownership of any of the pictures displayed on this website unless stated otherwise. Some of the images used on this website are taken from the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image.

 

There is no one left untouched by the charm of the multibillion-dollar global boom in cannabis. Its glorious journey from a criminalized drug to being used in over 20 countries for treating medical conditions.

No wonder the cannabis stocks are on the edge of a green rush. Don’t miss out on the happenings in the cannabis sector and take advantage of the growth phase of this sector by subscribing to our report on Marijuana stocks in Australia.

Find out the drivers for the rise in cannabis stock rates Even though the cannabis sector is in its growing phase, Australian cannabis stocks have already started to rise actively due to a hastily increasing patient base, and a legislative landscape that is gradually beginning to liberalise.

Outreach and future of cannabis stocks As countries liberalise regulation for medical and recreational use of cannabis, it is predicted that the industry would grow sharply in upcoming years The global cannabis market stands currently at around $8 billion and it is expected that the hemp derived CBD market to hit approximately $22 billion by 2022. 

Key Players in the sector Althea Group Holdings Limited (ASX: AGH) and Cann Group Limited (ASX: CAN) are amongst the top players. Other Australia cannabis market players are- MGC Pharmaceuticals Ltd (ASX: MXC), Elixinol Global Limited (ASX: EXL), THC Global Group Limited (ASX: THC), AusCann Group Holdings Limited (ASX: AC8)

CLICK HERE FOR YOUR FREE REPORT!
   
x
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK